Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)

INTRODUCTION: Dyspnoea is common in patients with interstitial lung disease (ILD) and often refractory to conventional treatment. Little is known about the efficacy of systemic morphine for dyspnoea in patients with ILD. The aim of this study is to estimate the efficacy of a single subcutaneous morp...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Yoshinobu, Morita, Tatsuya, Oyamada, Shunsuke, Ariyoshi, Keisuke, Yamaguchi, Takuhiro, Iwase, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130746/
https://www.ncbi.nlm.nih.gov/pubmed/34006542
http://dx.doi.org/10.1136/bmjopen-2020-043156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130746/
https://www.ncbi.nlm.nih.gov/pubmed/34006542
http://dx.doi.org/10.1136/bmjopen-2020-043156

Ejemplares similares